Topic: Data
at the Negotiation Table: Harmonizing Hard Skills and Soft Skills Speaker: Dr.
Robert Lo, Head of Access, Sustainability & External Engagement for Taiwan
& Hong Kong at UCB
Time: October
15, 2025 (Wednesday), 12:10 – 14:00 p.m.
Venue: The
Management Building, 11F, AI Lecture Hall
Registration: https://forms.office.com/r/afGDewBp3n or scan QR code on
poster
About the Speaker:
Po-Ching Lo (Robert Lo) is the Head of
Access, Sustainability & External Engagement for Taiwan & Hong Kong at
UCB. With over fifteen years of experience, he is a seasoned professional in
health technology assessment, pricing and reimbursement strategies, and health
economics and outcomes research (HEOR).
Robert's career spans pivotal roles in
leading pharmaceutical companies, including Novartis and AbbVie, where he led
market access strategies for new products in oncology, immunology, and rare
diseases. Before joining the industry, he served as a Senior Researcher at the
HTA division in Center for Drug Evaluation (CDE), Taiwan, where he conducted
economic evaluations for more than 60 reimbursement dossiers.
He holds a Ph.D. in Health and Welfare
Policy from National Yang-Ming University. This unique combination of
regulatory and industry experience equips him with a holistic perspective to
develop innovative access solutions and foster win-win collaborations with
stakeholders.
Abstract:
In Taiwan reimbursement journey of new
drug, data is not only the foundation of decision-making but also the key
language at the negotiation table. However, precise data alone is not enough to
drive national reimbursement decisions. Cross-functional coordination and soft
skills in communicating with government and stakeholders are essential to
ensure that evidence is understood and accepted. This talk will share practical
experiences from Taiwan’s pharmaceutical market access and product lifecycle,
guiding the audience to explore how data analytics (hard skills) and
negotiation communication (soft skills) perform in harmony in the AI era,
accelerating the inclusion of innovative medicines in health insurance coverage
and benefiting more patients.
Organizers: Graduate Institute of Health Data Science
※ Registration needed.
